Registry for subdural hematoma embolization
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This study is a registry for people with a subdural hematoma (a blood collection on the surface of the brain) who are planning to have a procedure to block one of the arteries in the scalp. The registry will track how these patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 98 years old.
- You have a certain type of subdural hematoma (blood collection on the brain) seen on a head CT done in the last 14 days.
- The blood collection is at least 10 mm thick on one side, or if on both sides, only one needs treatment and the other is smaller than 5 mm.
- You are willing to sign a consent form to participate and share your health information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment for a chronic blood clot on the brain that is causing symptoms. The treatment uses small coils to block the blood flow that feeds the clot, and may be done along with standard drainage surgery. This could help prevent the clot from coming back.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial compares different materials used during a procedure to treat chronic subdural hematoma, a collection of old blood on the brain's surface. The goal is to see which material works best to prevent the blood from coming back.
This trial tests a minimally invasive procedure to treat chronic subdural hematoma (a slow bleed on the brain). It aims to stop the bleeding and reduce the risk of needing surgery.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
This study collects information from patients diagnosed with chronic subdural hematoma (a type of bleeding on the brain) to better understand the condition and its treatment. By participating, you help doctors learn more about what helps patients recover.
Hear when a new Chronic Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.